Clene- Warrants (30/12/2025) Return on Equity

Clene- Warrants (30/12/2025) (CLNNW) currently reports a ROE of 178.2%. That is above the Healthcare sector average of 29.33%. Use the charts on this page to explore Clene- Warrants (30/12/2025)'s ROE history and peer comparisons.

Clene- Warrants (30/12/2025)'s ROE of 178.2% is higher than the Healthcare sector average of 29.33%. That is roughly 507.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Clene- Warrants (30/12/2025)'s current 178.2% should be judged against Healthcare norms (sector average: 29.33%) and against CLNNW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 178.2%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 29.33%. From there, open related valuation or income-statement pages for Clene- Warrants (30/12/2025), and consider following CLNNW for alerts when major investors trade the stock.

Clene- Warrants (30/12/2025) is classified in the Healthcare sector. On ROE, it currently shows 178.2% versus a sector average near 29.33%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CLNNW with unrelated industries.